<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00572351</url>
  </required_header>
  <id_info>
    <org_study_id>IRB 6110</org_study_id>
    <nct_id>NCT00572351</nct_id>
  </id_info>
  <brief_title>The Effects of Red Wine and White Wine on Blood Estrogen and Progesterone Levels</brief_title>
  <official_title>The Effects of Red Wine and White Wine on Blood Estrogen and Progesterone Levels</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cedars-Sinai Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cedars-Sinai Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Healthy pre-menopausal women will be recruited in order to test the effects of red wine and&#xD;
      white wine on blood estrogen and progesterone levels. The women will be randomized and&#xD;
      rotated through two different treatments (red wine, white wine). Estrone and estradiol are&#xD;
      hormones in the category of estrogens. It is known that the bodies of both men and women may&#xD;
      convert (or aromatize) a certain amount of naturally occurring testosterone into estrogen.&#xD;
      Aromatase inhibitors have been used to prevent this conversion, or aromatization, of&#xD;
      testosterone into estrogen, in the treatment of estrogen-dependent breast cancer in women.&#xD;
      This inhibition leads to a marked decrease in estrogen (estradiol and estrone) levels.&#xD;
      Naturally occurring aromatase inhibitors include grapes, grape juice, and red, but not white&#xD;
      wine. The aromatase inhibitory effects are attributed to wine phytochemicals and not to&#xD;
      alcohol. Based upon this information, the investigators will monitor the estrogen levels at&#xD;
      various phases in the menstrual cycles of women since hormone levels naturally vary&#xD;
      throughout the menstrual cycle. Several epidemiologic studies have found that there is a&#xD;
      correlation with moderate to high levels of alcohol consumption and breast cancer. Therefore,&#xD;
      study participants will be asked to drink only a eight ounces of wine which should have&#xD;
      minimal or no risk for the development of breast cancer.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2006</start_date>
  <completion_date type="Actual">March 2007</completion_date>
  <primary_completion_date type="Actual">March 2007</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>blood estrogen and progesterone levels</measure>
    <time_frame>15 minutes</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">44</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Red Wine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>White Wine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Red Wine</intervention_name>
    <description>8 ounces of assigned beverage (red wine) each evening and abstinence from any other alcoholic beverages, grape juice, grapes, or raisins.</description>
    <arm_group_label>Red Wine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>White Wine</intervention_name>
    <description>8 ounces of assigned beverage (white wine) each evening and abstinence from any other alcoholic beverages, grape juice, grapes, or raisins.</description>
    <arm_group_label>White Wine</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. female&#xD;
&#xD;
          2. pre-menopausal with regular ovulatory cycles for 12 months prior to the study&#xD;
&#xD;
          3. willingness and ability to participate in study requiring alcohol consumption&#xD;
&#xD;
          4. in general good health&#xD;
&#xD;
          5. BMI of 18.5-35&#xD;
&#xD;
          6. on regular, unrestricted diet&#xD;
&#xD;
          7. not currently, or within the past 3 months, using oral contraceptives or other hormone&#xD;
             replacement therapy&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. male&#xD;
&#xD;
          2. irregular menstrual cycles or vasomotor symptoms within the last 12 months&#xD;
&#xD;
          3. pregnant (or breast feeding)&#xD;
&#xD;
          4. any hormone therapy including phytoestrogens, oral contraceptives, SERMs (selective&#xD;
             estrogen receptor modulators), or androgens (or precursors) for three months prior to&#xD;
             the study&#xD;
&#xD;
          5. history of alcohol abuse&#xD;
&#xD;
          6. history of any estrogen-dependent neoplasia&#xD;
&#xD;
          7. high intake of dietary soy products&#xD;
&#xD;
          8. Minors &lt; age 21 years&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Glenn D Braunstein, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cedars Sinai Medical Cneter</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cedars-Sinai Women's Heart Center</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90048</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>January 11, 2007</study_first_submitted>
  <study_first_submitted_qc>December 12, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 13, 2007</study_first_posted>
  <last_update_submitted>April 22, 2019</last_update_submitted>
  <last_update_submitted_qc>April 22, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">April 23, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cedars-Sinai Medical Center</investigator_affiliation>
    <investigator_full_name>Noel Bairey Merz</investigator_full_name>
    <investigator_title>Director of the Barbra Streisand Women's Heart Center at Cedars-Sinai Medical Center</investigator_title>
  </responsible_party>
  <keyword>Wine</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

